Published in Women's Health Weekly, January 9th, 2003
The data were presented at the 25th Annual San Antonio Breast Cancer Symposium by John Park, MD, University of California San Francisco Comprehensive Cancer Center.
In this study, 16 women received treatment with the vaccine APC8024 and were evaluated for safety, immune response and exploratory signs of clinical benefit. At...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly